DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache

Information source: Albany Medical College
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Toothache

Intervention: hydrocodone/acetaminophen (Drug); bupivacaine (supraperiosteal nerve block) (Drug)

Phase: Phase 4

Status: Not yet recruiting

Sponsored by: Albany Medical College

Official(s) and/or principal investigator(s):
Wayne R Triner, DO, MPH, Principal Investigator, Affiliation: Albany Medical College

Overall contact:
Wayne R Triner, DO, MPH, Phone: 518-262-3773, Email: trinerw@mail.amc.edu

Summary

This study will compare the degree of pain control provided by two techniques for persons with toothache in an emergency department. The two techniques include;

- standard oral narcotic pain medication

- numbing the tooth with local anesthetic by needle injection

Clinical Details

Official title: The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache

Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Primary outcome: VAS determination of pain at 30 minutes following intervention

Secondary outcome: Numeric scale report or pain Number of prescribed analgesic pills taken

Detailed description: Background: Toothache is a common complaint among patients presenting to the emergency department. There are two commonly employed methods of alleviating this severe form of pain. Oral opioid analgesia is the most commonly utilized strategy for treating this pain. However, many emergency physicians and dentists employ a local anesthetic technique known as supraperiosteal nerve block. This study will compare the relative efficacy of these techniques.

Patients meeting enrollment criteria will be randomized to either receive a supraperiosteal nerve block or oral hydrocodone 10 mg/acetaminophen 650 mg. They will otherwise be managed identically. Reduction of pain scores between entry and 30 minutes post intervention will be compared as well as numeric pain scores obtained by phone contact 24 hours later. Secondary outcomes will include the proportion of individuals from each group filling prescriptions for pain medication and the number of pain pills taken.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Involvement of a single tooth

- Percussive tenderness of the crown of the suspect tooth

Exclusion Criteria:

- Age younger than 18 years

- Women who are breast feeding

- Allergy or intolerance to hydrocodone, bupivacaine or acetaminophen

- Pregnancy

- Involvement of multiple teeth

- Pain resulting from pericoronitis.

- Pain resulting from dental trauma occurring less than 90 days prior

- Pain of more than 96 hours duration

- Facial or neck swelling or tenderness

- Alteration in phonation

- Cognitive impairment

- Concurrent use of opiate analgesics

- Impairment of liver function

- Consumption of more than 4 grams of acetaminophen in the past 24 hours.

- Patients who are visually impaired.

Locations and Contacts

Wayne R Triner, DO, MPH, Phone: 518-262-3773, Email: trinerw@mail.amc.edu

Albany Medical Center Hospital, Albany, New York 12208, United States
Additional Information

Starting date: December 2007
Ending date: December 2008
Last updated: December 13, 2007

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008